Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss

Genes Chromosomes and Cancer

Volumn 22, Issue 4, 1998, Pages 305-311

  Moskaluk, Christopher A ^a,c   Hu, Jie ^b   Perlman, Elizabeth J ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 4; CHROMOSOME 5; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA HYBRIDIZATION; ESOPHAGUS CARCINOMA; FEMALE; GENE DELETION; GENE LOSS; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENOMIC LIBRARY; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; STOMACH NEOPLASMS;

EID: 0031744467     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199808)22:4<305::AID-GCC6>3.0.CO;2-Z     Document Type: Article

References (35)

1. al-Kasspooles M, Moore JH, Orringer MB, Beer DG (1993) Amplification and over-expression of the EGFR and erbB-2 genes in human esophagcal adenocarcinomas. Int J Cancer 54:213-219.
2. Amadori D, Maltoni M, Volpi A, Nanni O, Scarpi E, Renault B, Pellegata NS, Gaudio M, Magni E, Ranrani GN (1997) Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma. Cancer 79:226-232.
3. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ (1996) Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12:1873-1878.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JFJ (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289.
5. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR (1994) Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 129:609-614.
6. Daly JM, Karnell LH, Menck HR (1996) National Cancer Data Base report on esophageal carcinoma. Cancer 78:1820-1828.
7. Duhaylongsod FG, Gottfried MR, Iglehart JD, Vaughn AL, Wolfe WG (1995) The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. Ann Surg 221:677-683.
8. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32-41.
9. Haggitt RC (1994) Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25:982-993.
10. Hamilton SR, Smith RR, Camcrnn JL (1988) Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 19:942-948.
11. Hammoud XT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ (1996) Allelotype analysis of esophageal adenocarcinomas: Evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 56:4499-4502.
12. Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D (1995) c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol 48:129-132.
13. Houldsworth J, Chaganti RS (1994) Comparative genomic hybridization: an overview. Am J Pathol 145:1253-1260.
14. Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RS (1990) Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res 50:6417-6422.
15. Huang V, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, MeDaniel TK, Newkirk C, Resau JH, Sridhara R, et al. (1992) Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52:6525-6530.
16. Jankowski J, Coghill G, Hopwood D, Wormsley KG (1992) Oncogenes and onco-suppressor gene in aclenocarcinoma of the oesophagus. Gut 33:1033-1038.
17. Karhu R, Siitonen S, Tanner M, Keinanen M, Makipernaa A, Lehtinen M, Vilpo JA, Isola J (1997) Genetic aberrations in pediatric acute lymphoblastic leukemia by comparative genomic hybridization. Cancer Genet Cytogenet 95:123-129.
18. Levine MS, Caroline D, Thompson JJ, Kressel HY, Laufer I, Herlinger II (1984) Adenocarcinoma of the esophagus: Relationship to Barrett mucosa. Radiology 150:305-309.
19. Menke-Pluymers MB, van Drunen E, Vissers KJ, Mulder AH, Tilanus HW, Hagemeijer A (1996) Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet 90:109-117.
20. Mor O, Ranzani GN, Ravia Y, Rotman G, Gutman M, Manor A, Amadori D, Houldsworth J, Hollstein M, Schwab M, et al. (1993) DNA amplification in human gastric carcinomas. Cancer Genet Cytogenet 65:111-114.
21. Moskahik CA, Kern SE (1997) Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150:1547-1552.
22. Ogasawara S, Maesawa C, Tamura G, Satodate R (1994) Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas. Virchows Arch 424:607-611.
23. Powell J, McConkey CC (1990) Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62:440-443.
24. Powell SM, Papadopoulos N, Kinder KW, Smolinski KN, Meltzer SJ (1994) APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 107:1759-1763.
25. Rao PH, Muthew S, Kelson DP, Chaganti RS (1995) Cytogenetics of gastric and esophageal adenocareinomas. 3q deletion as a possible primary chromosomal change. Cancer Genet Cytogenet 81:139-143.
26. Rodriguez E, Rao PH, Ludanyi M, Altorki N, Albino AP, Kelsen DP, Jhanwar SC, Chayanti RS (1990) 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res 50:6410-6416.
27. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F, Reznikoff CA (1997) 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papiliomavirus 16 E7 tranformed human uroepithelial cells. Oncogene 14:551-560.
28. Seruca R, Suijkerhuijk RF, Gartner F, Criado B, Veiga I, Olde- Weghuis D, David L, Clastedo S, Sobrinho-Simoes M (1995) Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet Cytogenet 83:140-145.
29. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowhel D, Shadravan F, Hintz M, Kuo WL, et al. (1994) Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Res 54:4257-4260.
30. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, Kallioniemi OP (1996) Independent amplification and frequent co-amplifiearion of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56:3441-3445.
31. Thompson JJ, Zinsser KR, Enterline HT (1983) Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 14:42-61.
32. Voorter C, Joos S, Bringuier PP, Vallinga M, Poddighe P, Schalken J, du Manoir S, Ramaekers F, Lichter P, Hopman A (1995) Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 146:1341-1354.
33. Wallrapp C, Mullerpillasch F, Solinastoldo S, Lichter P, Friess H, Buchler M, Fink T, Adler G, Gress TM (1997) Characterization of a high copy number amplification at 6q24 In pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res 57:3135-3139.
34. Wang HH, Antonioli DA, Goldman H (1986) Comparative features of esophageal and gastric adenocarcinomas; Recent changes in type and frequency. Hum Pathol 17:482-487.
35. Weber-Hall S, McManus A, Anderson J, Nojima T, Abe S, PritchardJones K, Shipley J (1996) Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 17:7-13.